D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 37,951 224 World Ranking 9010 National Ranking 4796

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Internal medicine

Mohamad Navab focuses on Internal medicine, Endocrinology, Biochemistry, Paraoxonase and Lipoprotein. His Internal medicine research is multidisciplinary, incorporating perspectives in Immunology and Cardiology. Mohamad Navab combines subjects such as Inflammation, Proinflammatory cytokine and Monocyte with his study of Endocrinology.

His research in Biochemistry focuses on subjects like Apolipoprotein E, which are connected to Autoxidation, Electrospray ionization, Mass spectrometry and Arteriosclerosis. His Paraoxonase research incorporates themes from Genetically modified mouse, Low-density lipoprotein and Acute-phase protein. He interconnects Oxidative stress, Meal, Lipid oxidation, Cell biology and Superoxide in the investigation of issues within Lipoprotein.

His most cited work include:

  • From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
  • Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. (1551 citations)
  • Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. (1059 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Endocrinology, Apolipoprotein B, Biochemistry and Lipoprotein are his primary areas of study. Mohamad Navab combines topics linked to Immunology with his work on Internal medicine. In his study, Innate immune system is strongly linked to Inflammation, which falls under the umbrella field of Endocrinology.

His studies deal with areas such as Oral administration, Lesion, Anti-inflammatory, Reverse cholesterol transport and Efflux as well as Apolipoprotein B. His High-density lipoprotein study combines topics from a wide range of disciplines, such as Lipid oxidation and Low-density lipoprotein. His biological study spans a wide range of topics, including Endothelial stem cell and Cell biology.

He most often published in these fields:

  • Internal medicine (55.47%)
  • Endocrinology (52.34%)
  • Apolipoprotein B (33.59%)

What were the highlights of his more recent work (between 2012-2020)?

  • Internal medicine (55.47%)
  • Endocrinology (52.34%)
  • Inflammation (22.66%)

In recent papers he was focusing on the following fields of study:

Mohamad Navab focuses on Internal medicine, Endocrinology, Inflammation, LDL receptor and Apolipoprotein B. All of his Internal medicine and Lipoprotein, High-density lipoprotein, Low-density lipoprotein, Oxidative stress and Pulmonary hypertension investigations are sub-components of the entire Internal medicine study. His Lipoprotein research incorporates elements of Proinflammatory cytokine, Apolipoprotein E, Genetically modified mouse and Myocardial infarction.

The Endocrinology study combines topics in areas such as Serum amyloid A and Lysophosphatidic acid, Receptor. His Inflammation study combines topics in areas such as Tumor necrosis factor alpha, Biochemistry, Angiogenesis and Mechanism of action. His research in Apolipoprotein B tackles topics such as Computational biology which are related to areas like Combinatorial chemistry.

Between 2012 and 2020, his most popular works were:

  • Diesel Exhaust Induces Systemic Lipid Peroxidation and Development of Dysfunctional Pro-Oxidant and Pro-Inflammatory High-Density Lipoprotein (95 citations)
  • NOTCH1 is a mechanosensor in adult arteries (91 citations)
  • A novel approach to oral apoA-I mimetic therapy (74 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Internal medicine

His primary areas of investigation include Internal medicine, Endocrinology, Apolipoprotein B, Inflammation and Lipoprotein. His work deals with themes such as Signal transduction, Hydroxyeicosatetraenoic acid and Ultrafine particle, which intersect with Internal medicine. His Endocrinology research incorporates themes from Serum amyloid A and Lysophosphatidic acid.

Mohamad Navab interconnects Pulmonary hypertension, Computational biology, Cell growth and High-density lipoprotein in the investigation of issues within Apolipoprotein B. His biological study focuses on Proinflammatory cytokine. His Lipoprotein research includes elements of Area under the curve and Pharmacodynamics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)

4582 Citations

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Judith A. Berliner;Mohamad Navab;Alan M. Fogelman;Joy S. Frank.
Circulation (1995)

2612 Citations

Antiinflammatory Properties of HDL

Philip J. Barter;Stephen Nicholls;Kerry Anne Rye;G. M. Anantharamaiah.
Circulation Research (2004)

1567 Citations

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

A. D. Watson;J. A. Berliner;S. Y. Hama;B. N. La Du.
Journal of Clinical Investigation (1995)

1471 Citations

From Vulnerable Plaque to Vulnerable Patient

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells.
Circulation (2003)

1384 Citations

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

Diana M. Shih;Lingjie Gu;Yu Rong Xia;Mohamad Navab.
Nature (1998)

1346 Citations

Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo

Andrew D. Watson;Norbert Leitinger;Mohamad Navab;Kym F. Faull.
Journal of Biological Chemistry (1997)

1115 Citations

The Yin and Yang of Oxidation in the Development of the Fatty Streak: A Review Based on the 1994 George Lyman Duff Memorial Lecture

M Navab;J A Berliner;A D Watson;S Y Hama.
Arteriosclerosis, Thrombosis, and Vascular Biology (1996)

1015 Citations

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

B. J. Van Lenten;S. Y. Hama;F. C. De Beer;D. M. Stafforini.
Journal of Clinical Investigation (1995)

970 Citations

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

Mohamad Navab;G.M. Ananthramaiah;Srinivasa T. Reddy;Brian J. Van Lenten.
Journal of Lipid Research (2004)

915 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mohamad Navab

Michael Aviram

Michael Aviram

Technion – Israel Institute of Technology

Publications: 117

Aldons J. Lusis

Aldons J. Lusis

University of California, Los Angeles

Publications: 83

Joseph L. Witztum

Joseph L. Witztum

University of California, San Diego

Publications: 83

Stephen J. Nicholls

Stephen J. Nicholls

Monash University

Publications: 82

Clement E. Furlong

Clement E. Furlong

University of Washington

Publications: 82

Kerry-Anne Rye

Kerry-Anne Rye

University of New South Wales

Publications: 79

Alan T. Remaley

Alan T. Remaley

National Institutes of Health

Publications: 76

Daniel J. Rader

Daniel J. Rader

University of Verona

Publications: 72

G. M. Anantharamaiah

G. M. Anantharamaiah

University of Alabama at Birmingham

Publications: 65

Judith A. Berliner

Judith A. Berliner

University of California, Los Angeles

Publications: 63

Srinivasa T. Reddy

Srinivasa T. Reddy

University of California, Los Angeles

Publications: 60

Philip J. Barter

Philip J. Barter

University of New South Wales

Publications: 59

Lucio G. Costa

Lucio G. Costa

University of Washington

Publications: 56

M. John Chapman

M. John Chapman

Inserm

Publications: 55

Chun Yuan

Chun Yuan

University of Washington

Publications: 53

Prediman K. Shah

Prediman K. Shah

Cedars-Sinai Medical Center

Publications: 49

Trending Scientists

Peter Hästö

Peter Hästö

University of Turku

Byron C. Wallace

Byron C. Wallace

Northeastern University

Yehoshua Perl

Yehoshua Perl

New Jersey Institute of Technology

Alain J. Martin

Alain J. Martin

California Institute of Technology

Hua-Jin Zhai

Hua-Jin Zhai

Shanxi University

Gregory D. Scholes

Gregory D. Scholes

Princeton University

Isabel Roditi

Isabel Roditi

University of Bern

Eric D. Wieben

Eric D. Wieben

Mayo Clinic

Atsuo Amano

Atsuo Amano

Osaka University

Janusz Cofala

Janusz Cofala

International Institute for Applied Systems Analysis

Peter R. Thorne

Peter R. Thorne

University of Auckland

Chantal Bard

Chantal Bard

Université Laval

Rich S. W. Masters

Rich S. W. Masters

University of Waikato

Linda R. Watson

Linda R. Watson

University of North Carolina at Chapel Hill

Kiara R. Timpano

Kiara R. Timpano

University of Miami

Jean-Louis Vanoverschelde

Jean-Louis Vanoverschelde

Université Catholique de Louvain

Something went wrong. Please try again later.